30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Biomarin Pharmaceutical Inc (BMRN)

Track

In the last 90 days, Biomarin Pharmaceutical Inc. has seen net insider selling totaling $176,681.85, primarily driven by executive sales. Gregory R. Friberg, an Officer and EVP, Chief R&D Officer, made multiple sales. This activity occurred shortly after the company's last earnings report, which missed expectations.
Stock chart
Ticker: BMRN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Friberg Gregory R
EVP, Chief R&D Officer
2 sales — total 353,364 USD
Sale 7 May 2026
Value US$4,041,931.51 | Price 83.38 | Shares 46,993
Proposed sale 7 May 2026
Value US$583,950.69 | Price 89.31 | Shares 92,030
Sale 11 Mar 2026
Value US$4,954,275.10 | Price 180.00 | Shares 36,003
Proposed sale 11 Mar 2026
Value US$4,059,614.67 | Price 57.73 | Shares 83,659
Sale 26 Feb 2026
Value US$381,937.31 | Price 60.38 | Shares 6,326
Proposed sale 26 Feb 2026
Value US$381,937.07 | Price 60.38 | Shares 6,326
Sale 26 Feb 2026
Value US$1,599,102.96 | Price 61.36 | Shares 26,061
Proposed sale 26 Feb 2026
Value US$1,599,102.96 | Price 61.36 | Shares 26,061
Proposed sale 20 May 2025
Value US$105,927.66 | Price 59.31 | Shares 1,786
Planned sale 20 May 2025
Value US$105,927.66 | Price 59.31 | Shares 1,786
Planned sale 2 May 2025
Value US$17,723.16 | Price 64.92 | Shares 273
Proposed sale 2 May 2025
Value US$17,723.16 | Price 64.92 | Shares 273
Planned sale 19 Mar 2025
Value US$92,618.40 | Price 71.52 | Shares 1,295
Proposed sale 19 Mar 2025
Value US$92,618.40 | Price 71.52 | Shares 1,295
Sale 6 Mar 2025
Value US$501,355.38 | Price 71.28 | Shares 7,034
Proposed sale 6 Mar 2025
Value US$501,358.76 | Price 71.28 | Shares 7,034
Planned sale 24 Feb 2025
Value US$91,902.72 | Price 68.38 | Shares 1,344
Proposed sale 24 Feb 2025
Value US$91,902.72 | Price 68.38 | Shares 1,344
Sale 12 Nov 2024
Value US$350,323.56 | Price 66.37 | Shares 5,278
Proposed sale 12 Nov 2024
Value US$350,323.90 | Price 66.37 | Shares 5,278
Planned sale 13 Aug 2024
Value US$64,260.00 | Price 90.00 | Shares 714
Proposed sale 13 Aug 2024
Value US$64,260.00 | Price 90.00 | Shares 714
Proposed sale 4 Jun 2024
Value US$384,000.00 | Price 76.80 | Shares 5,000
Proposed sale 31 May 2024
Value US$2,310,740.00 | Price 74.54 | Shares 31,000
Planned sale 30 May 2024
Value US$375,950.00 | Price 75.19 | Shares 5,000
Proposed sale 30 May 2024
Value US$375,950.00 | Price 75.19 | Shares 5,000
Proposed sale 30 May 2024
Value US$1,503,800.00 | Price 75.19 | Shares 20,000
Proposed sale 30 May 2024
Value US$496,254.00 | Price 75.19 | Shares 6,600
Proposed sale 29 May 2024
Value US$1,161,486.00 | Price 73.98 | Shares 15,700
Planned sale 28 May 2024
Value US$209,225.35 | Price 75.29 | Shares 2,779
Planned sale 28 May 2024
Value US$2,834,576.30 | Price 74.46 | Shares 38,071
Proposed sale 28 May 2024
Value US$3,091,936.50 | Price 75.69 | Shares 40,850
Planned sale 10 May 2024
Value US$1,622,800.00 | Price 81.14 | Shares 20,000
Planned sale 10 May 2024
Value US$1,622,800.00 | Price 81.14 | Shares 20,000
Proposed sale 10 May 2024
Value US$1,622,800.00 | Price 81.14 | Shares 20,000
Planned sale 9 May 2024
Value US$1,632,400.00 | Price 81.62 | Shares 20,000
Planned sale 9 May 2024
Value US$1,632,400.00 | Price 81.62 | Shares 20,000
Proposed sale 9 May 2024
Value US$1,632,400.00 | Price 81.62 | Shares 20,000
Planned sale 2 May 2024
Value US$414,550.00 | Price 82.91 | Shares 5,000
Proposed sale 2 May 2024
Value US$414,550.00 | Price 82.91 | Shares 5,000
Planned sale 2 May 2024
Value US$157,268.50 | Price 85.01 | Shares 1,850
Proposed sale 2 May 2024
Value US$157,262.00 | Price 85.01 | Shares 1,850
Planned sale 12 Apr 2024
Value US$1,825,200.00 | Price 91.26 | Shares 20,000
Proposed sale 12 Apr 2024
Value US$1,825,200.00 | Price 91.26 | Shares 20,000
Planned sale 11 Apr 2024
Value US$1,819,800.00 | Price 90.99 | Shares 20,000
Proposed sale 11 Apr 2024
Value US$1,819,800.00 | Price 90.99 | Shares 20,000
Planned sale 10 Apr 2024
Value US$205,740.00 | Price 90.00 | Shares 2,286
Proposed sale 10 Apr 2024
Value US$205,740.00 | Price 90.00 | Shares 2,286
Planned sale 28 Mar 2024
Value US$2,173,340.68 | Price 88.34 | Shares 24,602
Proposed sale 28 Mar 2024
Value US$2,173,340.68 | Price 88.34 | Shares 24,602
Sale 6 Mar 2024
Value US$86,713.00 | Price 86.71 | Shares 1,000
Proposed sale 6 Mar 2024
Value US$86,713.30 | Price 86.71 | Shares 1,000
Planned sale 5 Mar 2024
Value US$348,280.00 | Price 87.07 | Shares 4,000
Proposed sale 5 Mar 2024
Value US$348,280.00 | Price 87.07 | Shares 4,000
Sale 5 Mar 2024
Value US$3,010,395.86 | Price 85.18 | Shares 35,341
Proposed sale 5 Mar 2024
Value US$3,010,397.21 | Price 85.18 | Shares 35,341
Sale 5 Mar 2024
Value US$85,510.00 | Price 85.51 | Shares 1,000
Proposed sale 5 Mar 2024
Value US$85,510.00 | Price 85.51 | Shares 1,000
Sale 27 Feb 2024
Value US$90,350.00 | Price 90.35 | Shares 1,000
Proposed sale 27 Feb 2024
Value US$90,350.00 | Price 90.35 | Shares 1,000
Planned sale 9 Feb 2024
Value US$1,324,200.00 | Price 88.28 | Shares 15,000
Proposed sale 9 Feb 2024
Value US$1,324,200.00 | Price 88.28 | Shares 15,000
Planned sale 8 Feb 2024
Value US$1,346,550.00 | Price 89.77 | Shares 15,000
Proposed sale 8 Feb 2024
Value US$1,346,550.00 | Price 89.77 | Shares 15,000
Planned sale 10 Jan 2024
Value US$963,800.00 | Price 96.38 | Shares 10,000
Proposed sale 10 Jan 2024
Value US$963,800.00 | Price 96.38 | Shares 10,000
Planned sale 9 Jan 2024
Value US$981,900.00 | Price 98.19 | Shares 10,000
Proposed sale 9 Jan 2024
Value US$981,900.00 | Price 98.19 | Shares 10,000
Planned sale 21 Dec 2023
Value US$939,900.00 | Price 93.99 | Shares 10,000
Proposed sale 21 Dec 2023
Value US$939,900.00 | Price 93.99 | Shares 10,000
Planned sale 13 Dec 2023
Value US$1,311,709.20 | Price 95.30 | Shares 13,764
Proposed sale 13 Dec 2023
Value US$1,311,709.20 | Price 95.30 | Shares 13,764
Planned sale 16 Aug 2023
Value US$450,000.00 | Price 90.00 | Shares 5,000
Proposed sale 16 Aug 2023
Value US$450,000.00 | Price 90.00 | Shares 5,000
Sale 10 Aug 2023
Value US$1,085,110.80 | Price 90.43 | Shares 12,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-11 2026-05-07 S Sale
Friberg Gregory R

EVP, Chief R&D Officer

Officer
46,993 +30.9%
83.38
US$4,041,932 		46,993 +30.9% 83.38 US$4,041,932
2026-05-07 2026-05-07 PrS Proposed sale
Friberg Gregory R

Officer

Officer
92,030
89.31
US$583,951 		92,030 89.31 US$583,951
2026-03-12 2026-03-11 S Sale
3.6
Guyer Charles Greg

EVP, Chief Technical Officer

Officer
36,003 +34.1%
180.00
US$4,954,275 		36,003 +34.1% 180.00 US$4,954,275
2026-03-11 2026-03-11 PrS Proposed sale
3.6
Guyer Charles Greg

Officer

Officer
16,486
60.46
US$996,749 		16,486 60.46 US$996,749
2026-02-26 2026-02-26 S Sale
Friberg Gregory R

EVP, Chief R&D Officer

Officer
6,326 -14.4%
60.38
US$381,937 		6,326 -14.4% 60.38 US$381,937
2026-02-26 2026-02-26 S Sale
2.9
Davis George Eric

EVP, Chief Legal Officer

Officer
26,061 -26.5%
61.36
US$1,599,103 		26,061 -26.5% 61.36 US$1,599,103
2026-02-26 2026-02-26 PrS Proposed sale
Friberg Gregory R

Officer

Officer
6,326
60.38
US$381,937 		6,326 60.38 US$381,937
2026-02-26 2026-02-26 PrS Proposed sale
2.9
Davis George Eric

Officer

Officer
26,061
61.36
US$1,599,103 		26,061 61.36 US$1,599,103
2025-05-20 2025-05-20 PrS Proposed sale
Burkhart Erin

Officer

Officer
1,786
59.31
US$105,928 		1,786 59.31 US$105,928
2025-05-20 2025-05-20 PlS Planned sale
Burkhart Erin

GVP, Chief Accounting Officer

Officer
1,786 -11.2%
59.31
US$105,928 		1,786 -11.2% 59.31 US$105,928
2025-05-06 2025-05-02 PlS Planned sale
Hubbard Cristin

EVP, Chief Commercial Officer

Officer
273 -0.8%
64.92
US$17,723 		273 -0.8% 64.92 US$17,723
2025-05-02 2025-05-02 PrS Proposed sale
Hubbard Cristin

Officer

Officer
273
64.92
US$17,723 		273 64.92 US$17,723
2025-03-20 2025-03-19 PlS Planned sale
Burkhart Erin

GVP, Chief Accounting Officer

Officer
1,295 -7.1%
71.52
US$92,618 		1,295 -7.1% 71.52 US$92,618
2025-03-19 2025-03-19 PrS Proposed sale
Burkhart Erin

Officer

Officer
1,295
71.52
US$92,618 		1,295 71.52 US$92,618
2025-03-07 2025-03-06 S Sale
3.6
Guyer Charles Greg

EVP, Chief Technical Officer

Officer
7,034 -7.4%
71.28
US$501,355 		7,034 -7.4% 71.28 US$501,355
2025-03-06 2025-03-06 PrS Proposed sale
3.6
Guyer Charles Greg

Officer

Officer
7,034
71.28
US$501,359 		7,034 71.28 US$501,359
2025-02-25 2025-02-24 PlS Planned sale
Burkhart Erin

GVP, Chief Accounting Officer

Officer
1,344 -9.3%
68.38
US$91,903 		1,344 -9.3% 68.38 US$91,903
2025-02-24 2025-02-24 PrS Proposed sale
Burkhart Erin

Officer

Officer
1,344
68.38
US$91,903 		1,344 68.38 US$91,903
2024-11-14 2024-11-12 S Sale
3.6
Guyer Charles Greg

EVP, Chief Technical Officer

Officer
5,278 -7.1%
66.37
US$350,324 		5,278 -7.1% 66.37 US$350,324
2024-11-12 2024-11-12 PrS Proposed sale
3.6
Guyer Charles Greg

Officer

Officer
5,278
66.37
US$350,324 		5,278 66.37 US$350,324
2024-08-15 2024-08-13 PlS Planned sale
Burkhart Erin

GVP, Chief Accounting Officer

Officer
714 -4.7%
90.00
US$64,260 		714 -4.7% 90.00 US$64,260
2024-08-13 2024-08-13 PrS Proposed sale
Burkhart Erin

Officer

Officer
714
90.00
US$64,260 		714 90.00 US$64,260
2024-06-04 2024-06-04 PrS Proposed sale
3.0
Ajer Jeffrey Robert

Officer

Officer
5,000
76.80
US$384,000 		5,000 76.80 US$384,000
2024-05-31 2024-05-31 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Former Director

Non-Executive Director
31,000
74.54
US$2,310,740 		31,000 74.54 US$2,310,740
2024-05-31 2024-05-30 PlS Planned sale
Mueller Brian

EVP, Chief Financial Officer

Officer
5,000 -6.5%
75.19
US$375,950 		5,000 -6.5% 75.19 US$375,950
2024-05-30 2024-05-30 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Former Director

Non-Executive Director
20,000
75.19
US$1,503,800 		20,000 75.19 US$1,503,800
2024-05-30 2024-05-30 PrS Proposed sale
Mueller Brian

Officer

Officer
5,000
75.19
US$375,950 		5,000 75.19 US$375,950
2024-05-30 2024-05-30 PrS Proposed sale
3.1
LAWLIS V BRYAN

Director

Non-Executive Director
6,600
75.19
US$496,254 		6,600 75.19 US$496,254
2024-05-29 2024-05-29 PrS Proposed sale
3.0
Ajer Jeffrey Robert

Officer

Officer
15,700
73.98
US$1,161,486 		15,700 73.98 US$1,161,486
2024-05-30 2024-05-28 PlS Planned sale
2.9
Davis George Eric

EVP, Chief Legal Officer

Officer
2,779 -4.7%
75.29
US$209,225 		2,779 -4.7% 75.29 US$209,225
2024-05-30 2024-05-28 PlS Planned sale
2.9
Davis George Eric

EVP, Chief Legal Officer

Officer
38,071 -39.2%
74.46
US$2,834,576 		38,071 -39.2% 74.46 US$2,834,576
2024-05-28 2024-05-28 PrS Proposed sale
2.9
Davis George Eric

Officer

Officer
40,850
75.69
US$3,091,936 		40,850 75.69 US$3,091,936
2024-05-13 2024-05-10 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
20,000 -4.0%
81.14
US$1,622,800 		20,000 -4.0% 81.14 US$1,622,800
2024-05-13 2024-05-10 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
20,000 -4.0%
81.14
US$1,622,800 		20,000 -4.0% 81.14 US$1,622,800
2024-05-10 2024-05-10 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director

Non-Executive Director
20,000
81.14
US$1,622,800 		20,000 81.14 US$1,622,800
2024-05-13 2024-05-09 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
20,000 -4.0%
81.62
US$1,632,400 		20,000 -4.0% 81.62 US$1,632,400
2024-05-13 2024-05-09 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
20,000 -4.0%
81.62
US$1,632,400 		20,000 -4.0% 81.62 US$1,632,400
2024-05-09 2024-05-09 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director

Non-Executive Director
20,000
81.62
US$1,632,400 		20,000 81.62 US$1,632,400
2024-05-06 2024-05-02 PlS Planned sale
3.0
Ajer Jeffrey Robert

EVP, Chief Commercial Officer

Officer
5,000 -7.0%
82.91
US$414,550 		5,000 -7.0% 82.91 US$414,550
2024-05-06 2024-05-02 PlS Planned sale
2.9
Davis George Eric

EVP, Chief Legal Officer

Officer
1,850 -3.2%
85.01
US$157,268 		1,850 -3.2% 85.01 US$157,268
2024-05-02 2024-05-02 PrS Proposed sale
2.9
Davis George Eric

Officer

Officer
1,850
85.01
US$157,262 		1,850 85.01 US$157,262
2024-05-02 2024-05-02 PrS Proposed sale
3.0
Ajer Jeffrey Robert

Officer

Officer
5,000
82.91
US$414,550 		5,000 82.91 US$414,550
2024-04-15 2024-04-12 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
20,000 -4.0%
91.26
US$1,825,200 		20,000 -4.0% 91.26 US$1,825,200
2024-04-12 2024-04-12 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director

Non-Executive Director
20,000
91.26
US$1,825,200 		20,000 91.26 US$1,825,200
2024-04-15 2024-04-11 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
20,000 -4.0%
90.99
US$1,819,800 		20,000 -4.0% 90.99 US$1,819,800
2024-04-11 2024-04-11 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director

Non-Executive Director
20,000
90.99
US$1,819,800 		20,000 90.99 US$1,819,800
2024-04-12 2024-04-10 PlS Planned sale
Burkhart Erin

GVP, Chief Accounting Officer

Officer
2,286 -12.4%
90.00
US$205,740 		2,286 -12.4% 90.00 US$205,740
2024-04-10 2024-04-10 PrS Proposed sale
Burkhart Erin

Officer

Officer
2,286
90.00
US$205,740 		2,286 90.00 US$205,740
2024-04-01 2024-03-28 PlS Planned sale
2.9
Davis George Eric

EVP, Chief Legal Officer

Officer
24,602 -30.6%
88.34
US$2,173,341 		24,602 -30.6% 88.34 US$2,173,341
2024-03-28 2024-03-28 PrS Proposed sale
2.9
Davis George Eric

Officer

Officer
24,602
88.34
US$2,173,341 		24,602 88.34 US$2,173,341
2024-03-07 2024-03-06 S Sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
1,000 -0.2%
86.71
US$86,713 		1,000 -0.2% 86.71 US$86,713
2024-03-06 2024-03-06 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director

Non-Executive Director
1,000
86.71
US$86,713 		1,000 86.71 US$86,713
2024-03-07 2024-03-05 PlS Planned sale
3.0
Ajer Jeffrey Robert

EVP, Chief Commercial Officer

Officer
4,000 -4.1%
87.07
US$348,280 		4,000 -4.1% 87.07 US$348,280
2024-03-07 2024-03-05 S Sale
2.5
FUCHS HENRY J

President, Worldwide R&D

Officer
35,341 -14.3%
85.18
US$3,010,396 		35,341 -14.3% 85.18 US$3,010,396
2024-03-07 2024-03-05 S Sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
1,000 -0.2%
85.51
US$85,510 		1,000 -0.2% 85.51 US$85,510
2024-03-05 2024-03-05 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director

Non-Executive Director
1,000
85.51
US$85,510 		1,000 85.51 US$85,510
2024-03-05 2024-03-05 PrS Proposed sale
2.5
FUCHS HENRY J

Officer

Officer
35,341
85.18
US$3,010,397 		35,341 85.18 US$3,010,397
2024-03-05 2024-03-05 PrS Proposed sale
3.0
Ajer Jeffrey Robert

Officer

Officer
4,000
87.07
US$348,280 		4,000 87.07 US$348,280
2024-02-29 2024-02-27 S Sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
1,000 -0.2%
90.35
US$90,350 		1,000 -0.2% 90.35 US$90,350
2024-02-27 2024-02-27 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director

Non-Executive Director
1,000
90.35
US$90,350 		1,000 90.35 US$90,350
2024-02-12 2024-02-09 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
15,000 -3.5%
88.28
US$1,324,200 		15,000 -3.5% 88.28 US$1,324,200
2024-02-09 2024-02-09 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director

Non-Executive Director
15,000
88.28
US$1,324,200 		15,000 88.28 US$1,324,200
2024-02-12 2024-02-08 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
15,000 -3.5%
89.77
US$1,346,550 		15,000 -3.5% 89.77 US$1,346,550
2024-02-08 2024-02-08 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director

Non-Executive Director
15,000
89.77
US$1,346,550 		15,000 89.77 US$1,346,550
2024-01-11 2024-01-10 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
10,000 -2.3%
96.38
US$963,800 		10,000 -2.3% 96.38 US$963,800
2024-01-10 2024-01-10 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director

Non-Executive Director
10,000
96.38
US$963,800 		10,000 96.38 US$963,800
2024-01-11 2024-01-09 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
10,000 -2.3%
98.19
US$981,900 		10,000 -2.3% 98.19 US$981,900
2024-01-09 2024-01-09 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director; Former Officer

Executive Director
10,000
98.19
US$981,900 		10,000 98.19 US$981,900
2023-12-22 2023-12-21 PlS Planned sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
10,000 -2.3%
93.99
US$939,900 		10,000 -2.3% 93.99 US$939,900
2023-12-21 2023-12-21 PrS Proposed sale
2.9
BIENAIME JEAN JACQUES

Director; Former Officer

Executive Director
10,000
93.99
US$939,900 		10,000 93.99 US$939,900
2023-12-14 2023-12-13 PlS Planned sale
2.9
Davis George Eric

EVP, Chief Legal Officer

Officer
13,764 -19.8%
95.30
US$1,311,709 		13,764 -19.8% 95.30 US$1,311,709
2023-12-13 2023-12-13 PrS Proposed sale
2.9
Davis George Eric

Officer

Officer
13,764
95.30
US$1,311,709 		13,764 95.30 US$1,311,709
2023-08-17 2023-08-16 PlS Planned sale
3.0
Ajer Jeffrey Robert

EVP, Chief Commercial Officer

Officer
5,000 -7.6%
90.00
US$450,000 		5,000 -7.6% 90.00 US$450,000
2023-08-16 2023-08-16 PrS Proposed sale
3.0
Ajer Jeffrey Robert

Officer

Officer
5,000
90.00
US$450,000 		5,000 90.00 US$450,000
2023-08-11 2023-08-10 S Sale
2.5
FUCHS HENRY J

President, Worldwide R&D

Officer
12,000 -6.4%
90.43
US$1,085,111 		12,000 -6.4% 90.43 US$1,085,111
Explore more

More insider trading research around Biomarin Pharmaceutical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America